Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Amneal Pharmaceuticals
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

AMNEAL PHARMACEUTICALS PRIVATE LIMITED

All Companies ›

Gujarat ›

Manufacturing of Chemical Products ›

Active

Updated: 24 Nov 2025

Amneal Pharmaceuticals Private Limited is a global pharmaceutical company that specializes in the development and manufacturing of generic and specialty medications. It offers a diverse portfolio of products including oral solids, injectables, and complex generics, addressing various therapeutic areas while ensuring high-quality, affordable healthcare solutions for patients.

Amneal Pharmaceuticals Private Limited, is an unlisted private company incorporated on 07 April, 2006. It is classified as a private limited company and is located in , Gujarat. It's authorized share capital is INR 640.00 cr and the total paid-up capital is INR 362.77 cr.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

, softgels, inhalation products, topicals, liquids

Company size

Auth Capital

₹ 640.0 Cr

Paidup Capital

₹ 362.8 Cr

Revenue

₹ 2500-2750 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

4.64%

₹ 2,665.3

EBITDA

10.8%

₹ 491.9

Net Profit

23.13%

₹ 179.5

Networth

9.93%

₹ 1,956.9

Borrowings

-9.65%

₹ 883.4

Assets

3.9%

₹ 3,341.4

Gross Margin

2.3

49.1 %

Operating Margin

0.98

18.6 %

Net Profit Margin

1.01

6.7 %

Return on Equity

0.98

9.2 %

ROCE

1.97

14.1 %

Debt to Equity

-0.1

0.5

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (13)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Rajeev Midha	08343797	7 years
Whole-time Director	Sureshkumar Punambhai Patel Shareholder	01856345	20 years
Director	Kanubhai Punambhai Patel	01883090	18 years
Director	Sandeep Radhakisan Raktate	03442482	2 years
Director	Rahul Maitra	10624671	2 years

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	1,420.6	1,731.8	2,013.8	2,523.2	2,648.9
Operating profit	298.3	334.1	366.1	444.0	491.9
Net profit	97.2	168.9	184.7	145.8	179.5
Gross margin	48.2	44.2	43.6	46.8	49.1
Operating margin	21.0	19.3	18.2	17.6	18.6
Net margin	6.8	9.7	9.1	5.7	6.7
Networth	865.0	1,032.6	1,928.7	1,780.1	1,956.9
Borrowings	488.5	486.4	603.6	977.8	883.4
Assets	1,686.9	1,938.6	2,935.8	3,216.0	3,341.4
Debt to equity	0.6	0.5	0.3	0.6	0.5
Current ratio	2.9	2.9	4.4	3.2	3.0
ROE	11.2	16.4	9.6	8.2	9.2
Days payable	62.0	63.0	61.0	59.0	62.0
WC days	133.0	141.0	271.0	156.0	151.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	308.0	308.0	362.8	362.8	362.8
Reserves	557.0	724.6	1,565.9	1,417.3	1,594.1
Borrowings +	488.5	486.4	603.6	977.8	883.4
Long term borrowings	488.5	486.4	487.5	801.1	679.2
Short term borrowings	-	-	116.1	176.7	204.2
Trade payables +	125.3	166.3	191.1	215.6	227.3
Days payable	62.0	63.0	61.0	59.0	62.0
Other liabilities +	333.4	419.6	403.5	458.2	501.1
Other non-current liabilities	53.4	69.1	81.4	155.2	149.3
Other current liabilities	154.8	184.2	131.0	87.4	124.5
Total liabilities	1,686.9	1,938.6	2,935.8	3,216.0	3,341.4
Fixed Assets +	579.8	578.5	664.2	1,257.3	1,233.0
Tangible assets	538.7	504.3	568.6	929.0	979.8
CWIP	34.9	69.0	91.5	322.4	247.0
Intangible assets	6.2	5.2	4.1	5.9	6.2
LT loans and advances	3.7	-	-	57.8	51.1
Other non-current assets	304.9	341.3	335.6	344.1	406.8
Current assets +	798.5	1,018.7	1,936.0	1,556.8	1,650.5
Inventories	547.9	783.5	801.1	1,079.0	1,000.8
Trade receivables	142.4	40.0	245.4	262.3	423.6
Cash and cash equivalents	25.6	27.6	69.1	29.1	53.1
ST loans and advances	-	14.5	657.3	1.2	73.9
Other current assets	82.5	153.1	163.1	185.1	99.2
Total assets	1,686.9	1,938.6	2,935.8	3,216.0	3,341.4

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	18.26	15.89	12.36	11.28	10.86
Reserves	33.02	37.38	53.34	44.07	47.71
Borrowings +	28.96	25.09	20.56	30.4	26.44
Long term borrowings	28.96	25.09	16.61	24.91	20.33
Short term borrowings	0.0	0.0	3.95	5.49	6.11
Trade payables	7.43	8.58	6.51	6.7	6.8
Other liabilities +	19.76	21.64	13.74	14.25	15.0
Other non-current liabilities	3.16	3.57	2.77	4.83	4.47
Other current liabilities	9.17	9.5	4.46	2.72	3.73
Total liabilities
Fixed Assets +	34.37	29.84	22.63	39.09	36.9
Tangible assets	31.93	26.02	19.37	28.89	29.32
CWIP	2.07	3.56	3.12	10.02	7.39
Intangible assets	0.37	0.27	0.14	0.18	0.19
LT loans and advances	0.22	0.0	0.0	1.8	1.53
Other non-current assets	18.08	17.61	11.43	10.7	12.17
Current assets +	47.33	52.55	65.94	48.41	49.4
Inventories	32.48	40.42	27.29	33.55	29.95
Trade receivables	8.44	2.06	8.36	8.16	12.68
Cash and cash equivalents	1.52	1.42	2.35	0.91	1.59
ST loans and advances	0.0	0.75	22.39	0.04	2.21
Other current assets	4.89	7.9	5.56	5.75	2.97
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	308.0	308.0	362.8	362.8	362.8
Reserves	578.9	744.4	1,563.8	1,438.1	1,579.3
Borrowings +	518.5	629.3	923.4	1,031.2	941.8
Long term borrowings	518.5	629.3	748.3	842.2	737.6
Short term borrowings	-	-	175.0	189.0	204.2
Trade payables +	128.0	179.0	212.2	227.0	239.4
Days payable	63.0	66.0	67.0	61.0	63.0
Other liabilities +	363.1	451.3	509.2	500.4	546.5
Other non-current liabilities	56.0	72.5	132.6	169.1	162.7
Other current liabilities	179.1	199.8	164.5	104.3	144.3
Total liabilities	1,768.5	2,133.0	3,359.1	3,332.4	3,430.3
Fixed Assets +	812.5	885.1	1,698.2	1,544.3	1,540.6
Tangible assets	649.1	629.5	1,100.3	1,032.9	1,082.3
CWIP	36.7	130.3	214.1	385.9	325.3
Intangible assets	126.6	125.3	383.8	125.4	133.0
LT loans and advances	4.5	-	-	-	-
Other non-current assets	107.0	156.8	122.8	140.2	200.8
Current assets +	844.5	1,091.1	1,538.1	1,647.9	1,689.0
Inventories	578.5	819.6	857.7	1,120.0	1,054.9
Trade receivables	152.9	42.3	352.9	280.5	464.2
Cash and cash equivalents	26.3	49.5	106.9	47.6	62.2
ST loans and advances	-	-	-	-	-
Other current assets	86.8	179.6	220.5	199.8	107.8
Total assets	1,768.5	2,133.0	3,359.1	3,332.4	3,430.3

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	17.42	14.44	10.8	10.89	10.58
Reserves	32.74	34.9	46.55	43.15	46.04
Borrowings +	29.32	29.5	27.49	30.94	27.45
Long term borrowings	29.32	29.5	22.28	25.27	21.5
Short term borrowings	0.0	0.0	5.21	5.67	5.95
Trade payables	7.24	8.39	6.32	6.81	6.98
Other liabilities +	20.53	21.16	15.16	15.02	15.93
Other non-current liabilities	3.17	3.4	3.95	5.07	4.74
Other current liabilities	10.13	9.37	4.9	3.13	4.21
Total liabilities
Fixed Assets +	45.94	41.5	50.56	46.34	44.91
Tangible assets	36.71	29.51	32.76	31.0	31.55
CWIP	2.08	6.11	6.37	11.58	9.48
Intangible assets	7.16	5.88	11.43	3.76	3.88
LT loans and advances	0.26	0.0	0.0	0.0	0.0
Other non-current assets	6.05	7.35	3.65	4.21	5.85
Current assets +	47.75	51.15	45.79	49.45	49.24
Inventories	32.71	38.43	25.53	33.61	30.75
Trade receivables	8.65	1.98	10.51	8.42	13.53
Cash and cash equivalents	1.49	2.32	3.18	1.43	1.81
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	4.91	8.42	6.57	6.0	3.14
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	1,420.6	1,731.8	2,013.8	2,523.2	2,648.9
Sales growth %	-0.4	21.91	16.29	25.29	4.98
Expenses +	1,306.1	1,518.0	1,792.6	2,370.0	2,421.4
Cost of goods	735.5	967.0	1,135.3	1,342.2	1,348.0
Employee cost	221.4	243.2	281.4	384.3	435.1
Other costs	165.4	187.5	231.0	352.7	374.0
Operating profit +	298.3	334.1	366.1	444.0	491.9
Operating margin %	21.0	19.3	18.2	17.6	18.6
Other income	4.7	12.4	25.8	23.9	16.4
Interest	70.7	13.3	41.9	130.4	101.1
Depreciation	113.2	106.9	103.0	160.4	163.3
Exceptional items	-	-	-	-	-
Profit before tax	119.2	226.2	247.0	177.0	243.9
Tax	22.0	57.3	62.3	31.3	64.4
Profit - disc. ops	-	-	-	-	-
Net profit	97.2	168.9	184.7	145.8	179.5
Net margin %	6.8	9.7	9.1	5.7	6.7

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.67	99.29	98.73	99.06	99.39
Expenses +	91.64	87.03	87.89	93.05	90.85
Cost of goods	51.61	55.44	55.66	52.7	50.57
Employee cost	15.53	13.94	13.8	15.09	16.32
Other costs	11.6	10.75	11.33	13.85	14.03
Operating profit	20.93	19.15	17.95	17.43	18.46
Other income	0.33	0.71	1.27	0.94	0.61
Interest	4.96	0.76	2.05	5.12	3.79
Depreciation	7.94	6.13	5.05	6.3	6.13
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	8.36	12.97	12.11	6.95	9.15
Tax	1.54	3.29	3.05	1.23	2.42
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	6.82	9.68	9.06	5.72	6.73

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	1,490.3	1,831.3	2,213.6	2,615.3	2,775.0
Sales growth %	-1.58	22.88	20.88	18.15	6.1
Expenses +	1,376.9	1,617.7	2,005.1	2,475.4	2,576.8
Cost of goods	739.1	992.2	1,163.3	1,354.9	1,385.5
Employee cost	238.9	262.8	333.8	415.6	481.5
Other costs	188.2	218.8	302.6	392.1	423.5
Operating profit +	324.1	357.5	413.9	452.7	484.4
Operating margin %	21.8	19.5	18.7	17.3	17.5
Other income	4.9	11.5	17.1	23.2	10.2
Interest	77.8	15.2	59.4	139.0	107.2
Depreciation	132.9	128.7	146.0	173.7	179.0
Exceptional items	-9.9	-	-	-	-
Profit before tax	108.4	225.1	225.6	163.2	208.3
Tax	20.6	58.2	62.9	29.9	64.3
Profit - disc. ops	-	-	-	-	-
Net profit	87.8	166.8	162.7	133.2	144.0
Net margin %	5.9	9.1	7.3	5.0	5.2

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.67	99.38	99.23	99.12	99.63
Expenses +	92.09	87.79	89.89	93.82	92.52
Cost of goods	49.43	53.85	52.15	51.35	49.75
Employee cost	15.98	14.26	14.97	15.75	17.29
Other costs	12.59	11.87	13.57	14.86	15.2
Operating profit	21.68	19.4	18.56	17.16	17.39
Other income	0.33	0.62	0.77	0.88	0.37
Interest	5.21	0.82	2.66	5.27	3.85
Depreciation	8.89	6.98	6.55	6.58	6.43
Exceptional items	-0.66	0.0	0.0	0.0	0.0
Profit before tax	7.25	12.21	10.11	6.18	7.48
Tax	1.38	3.16	2.82	1.13	2.31
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	5.87	9.05	7.3	5.05	5.17

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.6	0.5	0.3	0.6	0.5
Net Debt/Equity	0.5	0.4	0.3	0.5	0.4
Total Debt/Assets	0.3	0.2	0.2	0.3	0.3
Total Assets/Equity	1.9	1.9	1.5	1.8	1.7
Liquidity +
Current Ratio	2.9	2.9	4.4	3.2	3.0
Quick Ratio	0.9	0.7	2.6	1.0	1.2
Interest Coverage	4.2	25.1	8.7	3.4	4.9
Performance
Gross Margin	48.2	44.2	43.6	46.8	49.1
Operating Margin	21.0	19.3	18.2	17.6	18.6
Net Margin	6.8	9.7	9.1	5.7	6.7
Return +
Return on Equity	11.2	16.4	9.6	8.2	9.2
Pre-tax ROCE	16.9	18.2	12.2	12.2	14.1
Return on Assets	5.8	8.7	6.3	4.5	5.4
Pre-tax ROIC	13.9	15.2	10.7	10.4	11.8
Efficiency +
Days Payable	62.0	63.0	61.0	59.0	62.0
Days Inventory	272.0	296.0	258.0	293.0	271.0
Days Receivable	37.0	8.0	44.0	38.0	58.0
Fixed Asset Turnover	2.5	3.0	3.0	2.0	2.1
Total Asset Turnover	0.8	0.9	0.7	0.8	0.8
Working Capital
Cash Conversion Cycle	247.0	241.0	241.0	272.0	267.0
Working Capital Days	133.0	141.0	271.0	156.0	151.0

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.6	0.6	0.5	0.6	0.5
Net Debt/Equity	0.6	0.6	0.4	0.6	0.5
Total Debt/Assets	0.3	0.3	0.3	0.3	0.3
Total Assets/Equity	2.0	2.0	1.7	1.9	1.8
Liquidity +
Current Ratio	2.8	2.9	2.8	3.2	2.9
Quick Ratio	0.9	0.7	1.2	1.0	1.1
Interest Coverage	4.2	23.6	7.0	3.3	4.5
Performance
Gross Margin	50.4	45.8	47.5	48.2	50.1
Operating Margin	21.8	19.5	18.7	17.3	17.5
Net Margin	5.9	9.1	7.3	5.0	5.2
Return +
Return on Equity	9.9	15.8	8.4	7.4	7.4
Pre-tax ROCE	14.2	14.3	10.0	10.4	11.6
Return on Assets	5.0	7.8	4.8	4.0	4.2
Pre-tax ROIC	13.9	14.0	9.8	10.0	10.8
Efficiency +
Days Payable	63.0	66.0	67.0	61.0	63.0
Days Inventory	286.0	302.0	269.0	302.0	278.0
Days Receivable	37.0	8.0	58.0	39.0	61.0
Fixed Asset Turnover	1.8	2.1	1.3	1.7	1.8
Total Asset Turnover	0.8	0.9	0.7	0.8	0.8
Working Capital
Cash Conversion Cycle	260.0	244.0	260.0	280.0	276.0
Working Capital Days	132.0	142.0	163.0	157.0	145.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
AMNEAL LIFE SCIENCES PRIVATE LIMITED	Amalgamated	81.9 Cr	2	Gujarat
AMNEAL ONCOLOGY PRIVATE LIMITED	Active	33.7 Cr	4	Gujarat
SHIVANKA RESEARCH PRIVATE LIMITED	Active	1.0 L	1	Gujarat
KASHIV RESEARCH PRIVATE LIMITED	Active	17.7 Cr	1	Gujarat
AMNEAL HEALTHCARE PRIVATE LIMITED	Active	4.5 Cr	4	Gujarat
AMNEAL INJECTABLES PRIVATE LIMITED	Amalgamated	4.0 Cr	2	Gujarat
WHEELS INDIA NISWARTH FOUNDATION	Active	1.0 L	1	Gujarat
KASHIV BIOSCIENCES PRIVATE LIMITED	Active	99.0 Cr	1	Gujarat
RAKS PHARMA PRIVATE LIMITED	Active	1.6 Cr	4	Gujarat
AMNEAL BIOPHARMA SOLUTIONS PRIVATE LIMITED	Active	102.6 Cr	3	Gujarat
AMNEAL BIOPHARMA SYNTHESIS PRIVATE LIMITED	Active	10.0 L	3	Gujarat
PUNISKA HEALTHCARE PRIVATE LIMITED	Amalgamated	10.0 Cr	1	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
AMNEAL ONCOLOGY PRIVATE LIMITED	Gujarat	1998	₹ 33.7 Cr
AMNEAL INJECTABLES PRIVATE LIMITED	Gujarat	2020	₹ 4.0 Cr
AMNEAL HEALTHCARE PRIVATE LIMITED	Gujarat	2021	₹ 4.5 Cr
PUNISKA HEALTHCARE PRIVATE LIMITED	Gujarat	2017	₹ 10.0 Cr

Tofler Score

Very Good

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

RECEIVABLES DETERIORATING

Low Risk

HIGH INVENTORY

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U24231GJ2006PTC048109

PAN

AAGCA0781K

Incorporation

2006, 19.6 years

Company Email

ekta[dot]joshi[at]amneal[dot]com

Paid up Capital

₹ 362.8 Cr

Authorised Capital

₹ 640.0 Cr

AGM

Sep 2024

Type

Private

Others

FAQ - AMNEAL PHARMACEUTICALS PRIVATE LIMITED

What is the incorporation date of AMNEAL PHARMACEUTICALS PRIVATE LIMITED?

The incorporation date of AMNEAL PHARMACEUTICALS PRIVATE LIMITED is 07 April, 2006

What is the authorized share capital of AMNEAL PHARMACEUTICALS PRIVATE LIMITED?

The authorized share capital of AMNEAL PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 640.0 Cr.

What is the paid-up capital of AMNEAL PHARMACEUTICALS PRIVATE LIMITED?

The paid-up capital of AMNEAL PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 362.8 Cr.

What is the registered address of AMNEAL PHARMACEUTICALS PRIVATE LIMITED?

The registered address of AMNEAL PHARMACEUTICALS PRIVATE LIMITED is 901-911, ISCON ELEGANCE OPP. KARNAVATI CLUB, S.G.HIGHWAY, Ahmedabad, AHMEDABAD, Gujarat, India, 380015 - 380015

What is the CIN number of AMNEAL PHARMACEUTICALS PRIVATE LIMITED?

The CIN number of AMNEAL PHARMACEUTICALS PRIVATE LIMITED is U24231GJ2006PTC048109.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

AMNEAL PHARMACEUTICALS PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Company Network